Herb-antitumour drug interaction risks: retrospective integrative oncology study.
Noah SamuelsShir ShapiraEran Ben-AryePublished in: BMJ supportive & palliative care (2024)
The risk for interactions between herbal products and anticancer drugs is difficult to predict, with online search engines providing limited and inconsistent information. Clinical implications of herb-antitumor drug interactions need to be better understood, enabling patients and their oncology healthcare providers to make informed decisions regarding their care.